+49 30 648 35 164 service@chameleon-pharma.com

Interview to Jürgen Fritz

About Jürgen Fritz

Jür­gen Fritz (48) has a track record of more than twenty years of suc­cess­ful OTC and Rx expe­ri­ence, pri­mar­ily in the Emerg­ing Mar­kets, with a main focus on the CEE region, Turkey and the Near-Middle East. In 1996, he launched the VMS brand Dop­pel­herz in Rus­sia, the Baltics and Poland before mov­ing on to Proc­ter & Gam­ble Med­ical Hygiene in the CEE and NMEA mar­kets. In 2007, Mr Fritz started up Boehringer Ingelheim’s ‘last white spot’, a Turk­ish CHC busi­ness that manages brands such as Thomapyrin, Bus­co­pan, Phar­ma­ton, Dul­co­lax and Anti­s­tax. Mr. Fritz joined the Recor­dati Group in 2012 as a mem­ber of its local man­age­ment team.

Today, Mr. Fritz is mar­ried with two chil­dren and lives with his fam­ily in Mainz, Ger­many.

CPC German OTC and Pharma Expert Jürgen Fritz

CPC Team: What was your biggest chal­lenge when launching the Boehringer CHC busi­ness in Turkey?

JÜRGEN FRITZ: Being a con­ti­nen­tal, West­ern Euro­pean indi­vid­ual and man­ag­ing a team of nearly 100 sales reps and seven inter­nal head-counts, while at the same time establish­ing a suc­cess­ful Rx busi­ness within a highly volatile mar­ket envi­ron­ment, pro­vided me with sig­nif­i­cant chal­lenges on a daily basis. Cul­tural and man­age­r­ial dif­fer­ences, which may not be appar­ent at first glance, require a solid fun­da­men­tal knowl­edge and a sense of humour.

CPC Team: What was your nicest expe­ri­ence in Turkey?

FRITZ: The peo­ple! Even dur­ing the tough­est moments of my four-and-a-half years in Turkey – and there were indeed many of them! – the highly ded­i­cated spirit of my sales and mar­ket­ing team pro­vided me with the needed “Return On Invest­ment” and pride required to keep on going.

CPC Team: How do you feel about the future growth poten­tial for OTC brands and non-generic Rx brands in Turkey?

FRITZ: Turkey has a very strong local GX busi­ness, with com­pet­i­tive prices. It is rather diffi­cult to launch a new OTC brand in such a mar­ket envi­ron­ment. How­ever, due to an increas­ing pop­u­la­tion, as well as a sig­nif­i­cantly increas­ing number of mid­dle-class con­sumers, pre­mium west­ern OTC brands will find their way to Turk­ish consumers’ brains. As in many other Emerg­ing Mar­kets, OTC brands, which exhibit fast onset action (eg, RhinoPRONT®), def­i­nitely meet Turk­ish con­sumer expec­ta­tions. Busy people need fast and effec­tive medication!

CPC Team: What are the three key fac­tors in devel­op­ing a suc­cess­ful OTC/Rx busi­ness in Turkey?

FRITZ: 1) Select brands that deliver what they promise; 2) Do NOT expect to break even before your third year. Turkey is a strate­gic invest­ment that requires a long haul; 3) Solid man­age­r­ial and cross-cultural skills are crucial.

CPC Team: And finally…would you please share with our read­ers your favourite Istan­bul restau­rant?

FRITZ: Of course, there are plenty of those. Istan­bul is a colour­ful, busy and multi-cultural city with around 16-18 mil­lion inhab­i­tants from all over the globe. My favourite restau­rant is located in the for­merly Greek-Ottoman neigh­bour­hood of Fanari (today Fener), at the Golden Horn on the Euro­pean shores. It is called Asitane (www.asitanerestaurant.com). Asitane’s famous chef pre­pares “ancient Ottoman dishes” based on recipes that date back to the 15th cen­tury. Reser­va­tions are required. Enjoy!

About Chameleon Pharma Consulting

We at Chameleon Pharma Consulting are the experts with more than 20 years of experience in areas such as Consumer Healthcare, Pharma Rx, Cosmetics, Food Supplements, FMCG, Wholesale, Retail, Production.

Our services


International Strategy & Analysis

Licensing and M&A

International Business & Market Entry

Pharma Regulatory & Registration


Product Potential & Country Analysis

Pharma Executive Search

International Company Partner Identification

Market Reports and Analysis